CFO departure

Genpact LTD discloses CFO departure: Michael Weiner

Genpact LTD reported in a Form 8-K filed September 18, 2026 a change involving its Chief Financial Officer, Michael Weiner, effective September 8, 2026. The filing's own words are quoted below.

In the filing's words

On September 7, 2026, the Company and Mr. Weiner, its Chief Financial Officer, agreed that Mr. Weiner would step down as Chief Financial Officer, effective September 8, 2026, and remain employed by the Company in a transitional capacity through March 31, 2027 (the “Separation Date”).

Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.

CompanyGenpact LTD (G)
EventDeparture
OutgoingMichael Weiner
EffectiveSeptember 8, 2026
8-K filedSeptember 18, 2026
SEC CIK0001398659

Genpact LTD reported this change in a Form 8-K, Item 5.02, filed September 18, 2026. The filing's own words are quoted above.

Before and after at Genpact LTD

The adjacent records in the company's seat timeline.

Previous record

2 months ago· 2026-09-08TransitionG

Genpact Limited CFO transition: Sumita Pandit to succeed Michael Weiner

Other records naming Michael Weiner

2

The outgoing officer on this record, matched by name. Career line.

2 months ago· 2026-09-08TransitionG

Genpact Limited CFO transition: Sumita Pandit to succeed Michael Weiner

2026-02-26 · 10-K signature

Michael Weiner signed Genpact LTD's annual report as Chief Financial Officer (Principal Financial Officer)

Also filed in September 2026

Other CFO moves on the record that month. All moves.

6 weeks ago· 2026-09-30InterimACI

Albertsons Companies, Inc. names Cody Perdue interim CFO

6 weeks ago· 2026-09-30DepartureALDA

Atlantica Inc. discloses CFO departure: Shelley Goff

6 weeks ago· 2026-09-30TransitionCARL

Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein

6 weeks ago· 2026-09-30AppointmentLEVI

Levi Strauss & Co. appoints John Vandemore as CFO

6 weeks ago· 2026-09-30DeparturePTPI

Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein

6 weeks ago· 2026-09-30DepartureTCRX

TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello

Sources

  • sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26

Something wrong about Michael Weiner? Send a correction with the primary source.